|
- 2019
Immunotherapy in Hodgkin Lymphoma: The Road AheadDOI: https://doi.org/10.1016/j.it.2019.03.003 Abstract: Immune checkpoint blockade using antiprogrammed cell death protein 1 (anti-PD1) antibodies can be highly effective in treating HL
|